Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 8-K Event Other events
  2. 424B5 Offering Prospectus
  3. S-3MEF Other S-3MEF
  4. 424B5 Offering Prospectus
  5. 8-K Event Other events
  6. EFFECT Other Notice of Effectiveness
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-3 Offering Registration Statement
  10. 10-Q Report Quarterly Report
  11. 8-K Event Exhibits
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Director sold 2,500 shares at $4.34 ($10,850)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Exhibits
  20. 4 Open-market buy Director bought 50,000 shares at $3.98 ($199,000)

Page 13 of 38 · 755 filings